Most-Downgraded StocksMost-DowngradedNYSE:BSX Boston Scientific (BSX) Stock Price, News & Analysis $41.55 -0.64 (-1.52%) Closing price 03:58 PM EasternExtended Trading$41.64 +0.09 (+0.21%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Boston Scientific Stock (NYSE:BSX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Boston Scientific alerts:Sign Up Key Stats Today's Range$41.50▼$42.5250-Day Range$41.55▼$52.0252-Week Range$41.50▼$105.65Volume15.87 million shsAverage Volume20.43 million shsMarket Capitalization$60.21 billionP/E Ratio16.82Dividend YieldN/APrice Target$66.31Consensus RatingModerate Buy Company Overview Boston Scientific Corporation is a global medical technology company that develops, manufactures and markets devices used to diagnose and treat a broad range of medical conditions. Its products are designed to support minimally invasive procedures across areas including cardiovascular care, endoscopy, urology, pelvic health and neuromodulation. The company’s portfolio includes devices for interventional cardiology and peripheral interventions, electrophysiology and cardiac rhythm management, gastrointestinal and pulmonary procedures, kidney stone and prostate treatments, urinary and pelvic health, and chronic pain management. Boston Scientific also provides technologies used in the diagnosis and treatment of structural heart conditions and other complex diseases. Founded in 1979, Boston Scientific is headquartered in Marlborough, Massachusetts, and serves hospitals, healthcare professionals and patients in markets around the world. The company operates through a global network of research, manufacturing and commercial operations. Michael F. Mahoney serves as chairman and chief executive officer.AI Generated. May Contain Errors. Read More Boston Scientific Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks96th Percentile Overall ScoreBSX MarketRank™: Boston Scientific scored higher than 96% of companies evaluated by MarketBeat, and ranked 9th out of 884 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingBoston Scientific has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 22 buy ratings, 6 hold ratings, and 2 sell ratings.Upside PotentialBoston Scientific has a consensus price target of $66.31, representing about 59.6% upside from its current price of $41.55.Amount of Analyst CoverageBoston Scientific has been the subject of 16 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Boston Scientific's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth3.38% Earnings GrowthEarnings for Boston Scientific are expected to grow by 3.38% in the coming year, from $3.25 to $3.36 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Boston Scientific is 13.14, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.89.Price to Earnings Ratio vs. SectorThe P/E ratio of Boston Scientific is 13.14, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.14.Price to Earnings Growth RatioBoston Scientific has a PEG Ratio of 1.01. PEG Ratios around 1 indicate that a company is correctly valued.Price to Book Value per Share RatioBoston Scientific has a P/B Ratio of 2.52. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Boston Scientific's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.22% of the float of Boston Scientific has been sold short.Short Interest Ratio / Days to CoverBoston Scientific has a short interest ratio ("days to cover") of 2.35, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Boston Scientific has recently decreased by 3.46%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBoston Scientific does not currently pay a dividend.Dividend GrowthBoston Scientific does not have a long track record of dividend growth. News and Social Media1.9 / 5News Sentiment-0.03 News SentimentBoston Scientific has a news sentiment score of -0.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.42 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Boston Scientific this week, compared to 8 articles on an average week.Search Interest90 people have searched for BSX on MarketBeat in the last 30 days. This is an increase of 8% compared to the previous 30 days.MarketBeat FollowsOnly 20 people have added Boston Scientific to their MarketBeat watchlist in the last 30 days. This is a decrease of -20% compared to the previous 30 days. Company Ownership4.3 / 5Insider TradingAcquiring Shares Cluster Insider Buying3 insiders have purchased shares of Boston Scientific in the last three months. Multiple insiders buying is a strong bullish signal.Net Insider BuyingOver the last three months, insiders have purchased a net $9,385,210.00 in company stock, which represents 0.0156% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Boston Scientific insiders have bought more of their company's stock than they have sold. Specifically, they have bought $9,385,210.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders0.34% of the stock of Boston Scientific is held by insiders.Percentage Held by Institutions89.07% of the stock of Boston Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Boston Scientific's insider trading history. Receive BSX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BSX Stock News HeadlinesBoston Scientific Names Fitzgerald Executive Vice President & COO In New Operating RestructureOctober 7 at 3:22 PM | rttnews.comBoston Scientific (NYSE: BSX) names Fitzgerald COO, splits into 3 segmentsOctober 7 at 8:02 AM | americanbankingnews.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.October 7 at 1:00 AM | Porter & Company (Ad)Boston Scientific Announces New COO and Operating StructureOctober 7 at 6:30 AM | tipranks.comBoston Scientific appoints Joseph M. Fitzgerald Executive Vice President and Chief Operating OfficerOctober 7 at 6:00 AM | prnewswire.comCitigroup Issues Pessimistic Forecast for Boston Scientific (NYSE:BSX) Stock PriceOctober 7 at 1:18 AM | americanbankingnews.comElutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029October 1, 2026 | globenewswire.comBoston Scientific Corporation (NYSE:BSX) Stock Has Consensus Price Target of $70.19September 30, 2026 | americanbankingnews.comSee More Headlines BSX Stock Analysis - Frequently Asked Questions How have BSX shares performed this year? Boston Scientific's stock was trading at $95.29 on January 1st, 2026. Since then, BSX shares have decreased by 56.4% and is now trading at $41.5470. How were Boston Scientific's earnings last quarter? Boston Scientific Corporation (NYSE:BSX) announced its quarterly earnings data on Wednesday, July, 29th. The medical equipment provider reported $0.86 EPS for the quarter, topping analysts' consensus estimates of $0.83 by $0.03. The company's revenue was up 7.5% compared to the same quarter last year. Read the conference call transcript. Is Boston Scientific buying back stock? Boston Scientific's board initiated a stock buyback program on Monday, May 18th 2026, which allows the company to repurchase $5,000,000,000 in shares, according to EventVestor. This means that the company could repurchase up to 6.4% of its shares through open market purchases. Shares buyback programs are typically a sign that the company's management believes its shares are undervalued. Does Boston Scientific have any subsidiaries? The following companies are subsidiaries of Boston Scientific: VertiFlex, BTG, Augmenix, Veniti, Claret Medical, Cryterion Medical, nVision Medical, and more. Who are Boston Scientific's major shareholders? Top institutional investors of Boston Scientific include Congress Asset Management Co. (0.01%), North Point Portfolio Managers Corp OH (0.01%), Neville Rodie & Shaw Inc. and Persium Advisors LLC. Insiders that own company stock include Michael F Mahoney, Daniel J Brennan, Joseph Michael Fitzgerald, Vance R Brown, Eric Francis Yves Thepaut, Edward J Ludwig, Edward J Ludwig, Wendy Carruthers, Jeffrey B Mirviss, Ellen M Zane, Arthur C Butcher, John Bradley Sorenson, David C Habiger, Yoshiaki Fujimori, Cheryl Pegus and Charles J Dockendorff. View institutional ownership trends. How do I buy shares of Boston Scientific? Shares of BSX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Boston Scientific own? Based on aggregate information from My MarketBeat watchlists, some other companies that Boston Scientific investors own include BlackRock (BLK), Broadcom (AVGO), ServiceNow (NOW), UnitedHealth Group (UNH), The Goldman Sachs Group (GS), NVIDIA (NVDA) and Illinois Tool Works (ITW). Company Calendar Last Earnings7/29/2026Today10/07/2026Next Earnings (Estimated)10/28/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (2d) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 As of 2 days ago, BSX's financial health entered the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSE:BSX CIK885725 Webwww.bostonscientific.com Phone(508) 683-4000Fax508-683-5675Employees59,000Year Founded1979Price Target and Rating Average Price Target for Boston Scientific$66.31 High Price Target$118.00 Low Price Target$48.00 Potential Upside/Downside+59.6%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage30 Analysts Profitability EPS (Trailing Twelve Months)$2.47 Trailing P/E Ratio16.82 Forward P/E Ratio12.78 P/E Growth1.02Net Income$2.90 billion Net Margins17.50% Pretax Margin18.39% Return on Equity19.28% Return on Assets10.89% Debt Debt-to-Equity Ratio0.43 Current Ratio1.24 Quick Ratio0.74 Sales & Book Value Annual Sales$20.07 billion Price / Sales3.00 Cash Flow$3.95 per share Price / Cash Flow10.51 Book Value$16.49 per share Price / Book2.52Miscellaneous Outstanding Shares1,449,230,000Free Float1,444,303,000Market Cap$60.21 billion OptionableOptionable Beta0.58 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NYSE:BSX) was last updated on 10/7/2026 by MarketBeat.com Staff. From Our PartnersThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Boston Scientific Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Boston Scientific With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
